Financial incentives for organ donation (from living or brain-dead donors) have been considered ethically acceptable by some authors and have been accepted locally in some countries. In the United States of America, eight federal proposals have been rejected, while some kind of incentives have been approved at a local or state level. There is still a widespread concern that the acceptance of economic incentives could bring a commodification of the human body, constituting a "slippery slope" toward organ commercialism.
展开▼
